{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:38Z","timestamp":1790254298978,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4784,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1046\/j.1523-1755.2002.00601.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:50:54Z","timestamp":1047462654000},"page":"1611-1619","source":"Crossref","is-referenced-by-count":46,"title":["Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering"],"prefix":"10.1016","volume":"62","author":[{"given":"Bettina","family":"Haslinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Goedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin H.","family":"Toet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teake","family":"Kooistra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/089686089201200105","article-title":"Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis","volume":"12","author":"Dobbie","year":"1992","journal-title":"Perit Dial Int"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0015","series-title":"Textbook of Peritoneal Dialysis","first-page":"565","article-title":"Peritoneal inflammation and long-term changes in peritoneal structure and function","author":"Coles","year":"2000"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0020","first-page":"677","article-title":"Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells","volume":"10","author":"Sitter","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/089686089701700211","article-title":"Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients","volume":"17","author":"Goedde","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0030","first-page":"147","article-title":"Postoperative adhesions: Their treatment and relevance in clinical practice","volume":"75","author":"Menzies","year":"1993","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0035","first-page":"23","article-title":"Adhesion formation\/reformation","volume":"358","author":"Diamond","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/0140-6736(90)91125-T","article-title":"Peritoneal fibrinolytic activity and intra-abdominal adhesions","volume":"12","author":"Vipond","year":"1990","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0045","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood.V75.7.1490.1490","article-title":"Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells","volume":"75","author":"van Hinsbergh","year":"1990","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0039-6060(96)80196-6","article-title":"Fibrinolysis in human peritoneum during operation","volume":"119","author":"Holmdahl","year":"1996","journal-title":"Surgery"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0055","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J Lipid Res"},{"issue":"Suppl 71","key":"10.1046\/j.1523-1755.2002.00601.x_bb0060","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1046\/j.1523-1755.1999.07133.x","article-title":"Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients","volume":"56","author":"Nishizawa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0065","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0021-9150(97)00319-5","article-title":"Direct vascular effects of HMG-CoA reductase inhibitors","volume":"137","author":"Bellosta","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005344-199202000-00013","article-title":"Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits","volume":"19","author":"Zhu","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0075","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1681\/ASN.V981377","article-title":"Lovastatin modulates in vivo and in vitro the plasminogen activator\/plasmin system of rat proximal tubular cells: Role of geranylgeranylation and Rho proteins","volume":"9","author":"Essig","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0272-6386(12)80587-7","article-title":"Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome","volume":"15","author":"Harris","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.ATV.20.2.556","article-title":"HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells","volume":"20","author":"Bourcier","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.RES.83.7.683","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins","volume":"83","author":"Essig","year":"1998","journal-title":"Circ Res"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0037-1613968","article-title":"Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells","volume":"84","author":"Mussoni","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(00)00454-8","article-title":"Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells","volume":"152","author":"Lopez","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0105","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1073\/pnas.76.11.5674","article-title":"An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization","volume":"76","author":"Maciag","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0006-2952(98)00322-0","article-title":"Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein: Farnesyl transferase","volume":"57","author":"Cohen","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0115","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/bj2470605","article-title":"Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells","volume":"247","author":"Kooistra","year":"1987","journal-title":"Biochem J"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0038-1657277","article-title":"A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma","volume":"48","author":"Verheijen","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1523-1755.1999.00244.x","article-title":"Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator","volume":"55","author":"Sitter","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0140","first-page":"315","article-title":"Enzymology and biology of CaaX protein prenylation","volume":"54","author":"Fu","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.biochem.68.1.157","article-title":"Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway","volume":"68","author":"Edwards","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0150","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1073\/pnas.94.20.10588","article-title":"The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism","volume":"94","author":"Forman","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0155","first-page":"115","article-title":"Clostridium botulinum C3 ADP-ribosyltransferase","volume":"175","author":"Aktories","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0160","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1006\/bbrc.1999.1202","article-title":"Cytoskeletal reorganization leads to induction of the urokinase-type plasminogen activator gene by activating FAK and Src and subsequently the Ras\/Erk signaling pathway","volume":"262","author":"Irigoyen","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1097-4652(199808)176:2<293::AID-JCP7>3.0.CO;2-J","article-title":"Cell shape-dependent pathway of plasminogen activator inhibitor type-1 gene expression requires cytoskeletal reorganization","volume":"176","author":"Hawks","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0170","first-page":"6511","article-title":"Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells","volume":"61","author":"Wickstrom","year":"2001","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/089686089701700204","article-title":"Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD","volume":"17","author":"Dobbie","year":"1997","journal-title":"Perit Dial Int"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-2168.2001.01647.x","article-title":"Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1","volume":"88","author":"Falk","year":"2001","journal-title":"Br J Surg"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1432-1033.1997.00596.x","article-title":"Differences in metabolism and isomerization of all-trans-retinoic acid and 9-cis-retinoic acid between human endothelial cells and hepatocytes","volume":"247","author":"Lansink","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.bi.61.070192.002035","article-title":"Protein isoprenylation and methylation at carboxyl-terminal cysteine residues","volume":"61","author":"Clarke","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0195","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1096\/fasebj.7.9.8330683","article-title":"Emerging concepts in the Ras superfamily of GTP-binding proteins","volume":"7","author":"Bokoch","year":"1993","journal-title":"FASEB J"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2165\/00003088-199631050-00003","article-title":"Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors","volume":"31","author":"Desager","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0205","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1046\/j.1523-1755.2002.00601.x_bb0210","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.HYP.34.4.987","article-title":"State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action","volume":"34","author":"Faggiotto","year":"1999","journal-title":"Hypertension"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815487174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815487174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:54:14Z","timestamp":1622336054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815487174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0085253815487174"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00601.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}